Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2017 1
2018 2
2019 3
2020 3
2021 5
2022 6
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety results after >3.5 years of treatment with the Bruton's tyrosine kinase inhibitor evobrutinib in relapsing multiple sclerosis: Long-term follow-up of a Phase II randomised clinical trial with a cerebrospinal fluid sub-study.
Montalban X, Piasecka-Stryczynska K, Kuhle J, Benkert P, Arnold DL, Weber MS, Seitzinger A, Guehring H, Shaw J, Tomic D, Hyvert Y, Harlow DE, Dyroff M, Wolinsky JS. Montalban X, et al. Among authors: shaw j. Mult Scler. 2024 Apr;30(4-5):558-570. doi: 10.1177/13524585241234783. Epub 2024 Mar 4. Mult Scler. 2024. PMID: 38436271 Clinical Trial.
Asia-Inclusive Global Development of Enpatoran: Results of an Ethno-Bridging Study, Intrinsic/Extrinsic Factor Assessments and Disease Trajectory Modeling to Inform Design of a Phase II Multiregional Clinical Trial.
Klopp-Schulze L, Gopalakrishnan S, Yalkinoglu Ö, Kuroki Y, Lu H, Goteti K, Krebs-Brown A, Nogueira Filho M, Gradhand U, Fluck M, Shaw J, Dong J, Venkatakrishnan K. Klopp-Schulze L, et al. Among authors: shaw j. Clin Pharmacol Ther. 2024 Feb 28. doi: 10.1002/cpt.3216. Online ahead of print. Clin Pharmacol Ther. 2024. PMID: 38415785
Science funding policy and the COVID-19 pandemic.
Sikimić V, Stuart M, Shaw J. Sikimić V, et al. Among authors: shaw j. Int J Risk Saf Med. 2022;33(3):211-216. doi: 10.3233/JRS-227015. Int J Risk Saf Med. 2022. PMID: 35275560 No abstract available.
On the very idea of pursuitworthiness.
Shaw J. Shaw J. Stud Hist Philos Sci. 2022 Feb;91:103-112. doi: 10.1016/j.shpsa.2021.11.016. Epub 2021 Dec 9. Stud Hist Philos Sci. 2022. PMID: 34896786
20 results